Partnering “Medicines of Russia — Towards an Interdisciplinary Dialogue. From Pharmacovigilance Quality to Quality of Life”

On September 26, 2025, the Partnering event “Medicines of Russia — Towards an Interdisciplinary Dialogue. From Pharmacovigilance Quality to Quality of Life” will take place in Kaliningrad.

The co‑organizers of the Partnering event are: the Association of Russian Pharmaceutical Manufacturers (ARPM), the Ministry of Health of the Kaliningrad Region, the Association of Pharmacovigilance and Medical Device Safety Monitoring, and Pharmcompliance Pharmacovigilance Agency LLC, with the support of the Public Council under Roszdravnadzor and the Territorial Body of the Federal Service for Surveillance in Healthcare of the Kaliningrad Region.

The business program of the conference consists of two interconnected parts:

The first part will focus on discussing federal and regional procurement procedures for medicinal products within the framework of state guarantees, as well as pricing under sanction restrictions.

The second part will address pharmacovigilance issues, rational pharmacotherapy, quality and safety control of medicinal products, the operation of pharmacovigilance departments within companies, and pharmacovigilance inspections.

Invited participants include representatives of federal and regional executive authorities, heads and specialists of pharmaceutical manufacturers, representatives of professional associations and communities, leading experts in pharmacovigilance, including from the Republic of Belarus, the Republic of Bulgaria, and the Republic of Kazakhstan. Among the invited speakers are:

• Inna Svyatenko, Deputy Chairperson of the Federation Council;
• Badma Bashankaev, First Deputy Chair of the Health Protection Committee of the State Duma;
• Angelika Meister, Deputy Chairperson of the Government of the Kaliningrad Region, Minister of Social Policy of the Kaliningrad Region;
• Sergey Glagolev, Deputy Minister of Health of the Russian Federation;
• Ekaterina Priezzheva, Deputy Minister of Industry and Trade of the Russian Federation;
• Timofey Nizhegorodtsev, Deputy Head of the Federal Antimonopoly Service of Russia;
• Dmitry Parkhomenko, Deputy Head of Roszdravnadzor;
• Sergey Dmitriev, Minister of Health of the Kaliningrad Region;
• Vladimir Rodin, First Deputy Prosecutor of the Kaliningrad Region;
• Yury Zhulev, Co‑Chair of the All‑Russian Patient Union;
• Valery Alekseev, Head of the Investigative Bureau of the People’s Front (ONF);
• Viktor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers, Chairman of the Public Council under Roszdravnadzor;
• Kirill Gorelov, Acting Head of the Department for Organization of State Quality Control of Medical Products, Roszdravnadzor;
• Vadim Kalinichenko, Representative of the Department for Regulation of Medicinal Products and Medical Devices, Ministry of Health of Russia;
• Erendzhen Bashankaev, Head of the Territorial Body of Roszdravnadzor for the Kaliningrad Region;
• Vitaly Polivanov, Head of the Pharmacovigilance Center of the Federal State Budgetary Institution “IMTSEUAOSMP” of Roszdravnadzor;
• Irina Efremova, Head of the Republican Clinical Pharmacology Laboratory of the State Enterprise “Center for Examinations and Tests in Healthcare” of the Republic of Belarus;
• Malik Abdrakhmanov, Head of the Department of Pharmacovigilance, Safety Monitoring, Efficacy and Quality of Medical Devices of the RSE on PVC “National Center for Expertise of Medicines and Medical Devices” of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan;
• Alexander Khadzhidis, Chairman of the Professional Medical Association of Clinical Pharmacologists of St. Petersburg;
• Ivan Krysanov, Professor of the Department of Therapy with a Course in Pharmacology and Pharmacy, MINO, ROSBIOTECH;
• Ivan Anosov, Chairman of the Association of Pharmacovigilance and Medical Device Safety Monitoring;
• Igor Kaminsky, Deputy General Director for Quality Assurance and Scientific Work, Pharmcompliance Pharmacovigilance Agency LLC;
• Svetlana Setkina, Qualified Person for Pharmacovigilance, Head of the Drug Safety Department, BIOCAD JSC;
• Dimo Angelov, Pharmacovigilance Expert, Patient Safety Manager, Sandoz, Republic of Bulgaria;
• Alexander Matveev, Associate Professor of the Department of Clinical Pharmacology and Therapy named after Academician B.E. Votchal, FSBEI FVE RMACPE of the Ministry of Health of Russia;
• Anna Kashirskikh, General Director of Pharmcompliance Pharmacovigilance Agency LLC, Certified Expert of Roszdravnadzor.

Conference participation formats: in‑person in Kaliningrad (Kaiserhof Hotel & Spa 4*), as well as online.